ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 173 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,930,000 | +38.6% | 34,455 | +1.1% | 0.02% | +28.6% |
| Q2 2021 | $4,277,000 | -4.8% | 34,080 | +2.8% | 0.01% | -12.5% |
| Q1 2021 | $4,494,000 | +13.3% | 33,142 | +6.9% | 0.02% | +14.3% |
| Q4 2020 | $3,968,000 | +5.2% | 31,017 | -7.5% | 0.01% | -6.7% |
| Q3 2020 | $3,773,000 | +14.5% | 33,530 | -3.1% | 0.02% | +7.1% |
| Q2 2020 | $3,296,000 | -25.5% | 34,598 | -29.7% | 0.01% | -33.3% |
| Q1 2020 | $4,424,000 | +69.5% | 49,226 | 0.0% | 0.02% | +110.0% |
| Q4 2019 | $2,610,000 | +17.1% | 49,226 | -12.7% | 0.01% | +11.1% |
| Q3 2019 | $2,228,000 | -38.4% | 56,400 | -35.9% | 0.01% | -30.8% |
| Q2 2019 | $3,615,000 | -11.8% | 88,000 | 0.0% | 0.01% | -13.3% |
| Q1 2019 | $4,098,000 | +77.6% | 88,000 | +66.0% | 0.02% | +50.0% |
| Q4 2018 | $2,308,000 | -23.9% | 53,000 | 0.0% | 0.01% | -9.1% |
| Q3 2018 | $3,033,000 | +17.9% | 53,000 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $2,572,000 | +24.1% | 53,000 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $2,072,000 | -7.9% | 53,000 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $2,249,000 | +13.7% | 53,000 | 0.0% | 0.01% | +12.5% |
| Q3 2017 | $1,978,000 | +261.6% | 53,000 | +194.4% | 0.01% | +300.0% |
| Q2 2017 | $547,000 | +14.9% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $476,000 | +3.7% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $459,000 | -29.5% | 18,000 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $651,000 | +6.4% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $612,000 | +28.8% | 18,000 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $475,000 | -72.9% | 18,000 | -50.0% | 0.00% | -50.0% |
| Q4 2015 | $1,756,000 | +292.0% | 36,000 | +100.0% | 0.00% | +100.0% |
| Q3 2015 | $448,000 | -21.4% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $570,000 | -16.8% | 18,000 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $685,000 | -2.3% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $701,000 | +28.9% | 18,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $544,000 | -11.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $611,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |